title: Erythroid progenitors differentiate and mature in response to endogenous erythropoietin.
abstract: We reported previously that stimulation of glycoprotein 130 (gp130) by a combination of human IL-6 and soluble IL-6 receptor (sIL-6R) could support proliferation, differentiation, and terminal maturation of erythroid cells in the absence of erythropoietin (EPO) from human CD34(+) cells in culture with stem cell factor (SCF). This observation suggested that differentiation of hematopoietic stem/progenitor cells to erythroid cells progressed according to an intrinsic program and that EPO receptor (EPOR) could be replaced by other cytokine receptors. In other words, EPOR appeared to be dispensable for erythropoiesis. Here we examined the role of EPOR in erythropoiesis stimulated by SCF, sIL-6R, and IL-6. Surprisingly, reduction of EPOR expression using antisense oligodeoxynucleotides suppressed erythropoiesis stimulated not only by SCF and EPO, but also by SCF, sIL-6R, and IL-6. EPO mRNA was detected in erythroid cells but not myeloid cells cultured in the presence of SCF, sIL-6R, and IL-6. Furthermore, high concentrations of anti-EPO-neutralizing antibody abrogated erythropoiesis in cultures without exogenous EPO. Based on these results, we suggest that erythroid progenitors themselves secrete EPO and that they have the potential to differentiate and mature in response to this endogenous EPO.
authors.affiliation: Department of Clinical Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Sato
authors.forename: T
authors.initials: T
authors.lastname: Maekawa
authors.forename: S
authors.initials: S
authors.lastname: Watanabe
authors.forename: K
authors.initials: K
authors.lastname: Tsuji
authors.forename: T
authors.initials: T
authors.lastname: Nakahata
mesh_terms: D000906:Antibodies / Q000494:pharmacology; D019898:Autocrine Communication; D002454:Cell Differentiation / Q000187:drug effects; D019070:Cell Lineage; D015672:Erythroid Precursor Cells / Q000166:cytology* / Q000187:drug effects; D004920:Erythropoiesis / Q000502:physiology*; D004921:Erythropoietin / Q000276:immunology / Q000378:metabolism*; D005914:Globins / Q000096:biosynthesis; D006021:Glycophorins / Q000096:biosynthesis; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism; D020319:Oligodeoxyribonucleotides, Antisense / Q000494:pharmacology; D012333:RNA, Messenger / Q000032:analysis; D017467:Receptors, Erythropoietin / Q000235:genetics / Q000378:metabolism*; D019947:Receptors, Interleukin-6 / Q000378:metabolism; D019089:Stem Cell Factor / Q000378:metabolism
chemical_list: D000906:Antibodies; D006021:Glycophorins; D015850:Interleukin-6; D020319:Oligodeoxyribonucleotides, Antisense; D012333:RNA, Messenger; D017467:Receptors, Erythropoietin; D019947:Receptors, Interleukin-6; D019089:Stem Cell Factor; D004921:Erythropoietin; D005914:Globins